Internal Medicine · Los Angeles, CA
NPI
1295811966
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
966 S Western Ave, Ste 208
Los Angeles, CA, 90006
Phone (323) 731-2001
Groups this clinician bills Medicare through
Medicare paid, 2024
$203K
6,494 services
Medicare patients, 2024
292
Average age 83
Drug cost, 2024
$4.7M
40,041 prescriptions
Company payments, 2025
$238
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jae Y Yoo was code 99213 (office e&m - established), 1,560 times for 249 patients. In total Jae Y Yoo billed 6,494 services in 31 codes, and Medicare paid $203K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,560 | 249 | $73.61 | $115K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 992 | 157 | $0.33 | $325 |
| 82962 Clinical Chemistry | Office | 924 | 137 | $3.21 | $2,966 |
| 96372 Injection Administration | Office | 615 | 226 | $11.58 | $7,124 |
| 36415 Venipuncture Blood Collection | Office | 493 | 240 | $8.65 | $4,264 |
| 99441 Telephone Services | Office | 304 | 113 | $45.41 | $14K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 220 | 99 | $0.43 | $95.3 |
| G0008 Administration of influenza virus vaccine | Office | 160 | 160 | $35.02 | $5,603 |
| 90656 Vaccine Product | Office | 160 | 160 | $21.90 | $3,504 |
| 99214 Office E&M - Established | Office | 135 | 102 | $89.73 | $12K |
| 99212 Office E&M - Established | Office | 131 | 70 | $48.88 | $6,403 |
| 81003 Clinical Chemistry | Office | 120 | 83 | $2.20 | $264 |
| 87880 Immunoassay | Office | 119 | 92 | $16.20 | $1,928 |
| 20610 Joint Injection | Office | 91 | 77 | $50.32 | $4,579 |
| 20605 Joint Injection | Office | 77 | 65 | $46.11 | $3,551 |
By year: 2022 $302K for 9,531 services; 2023 $236K for 7,740 services; 2024 $203K for 6,494 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 924 | 137 | $3.21 | $2,966 |
| 36415 Venipuncture Blood Collection | 493 | 240 | $8.65 | $4,264 |
| 81003 Clinical Chemistry | 120 | 83 | $2.20 | $264 |
| 87880 Immunoassay | 119 | 92 | $16.20 | $1,928 |
Medicare prescription drug claims, 2024
In 2024, the drug Jae Y Yoo prescribed most often to Medicare patients was Atorvastatin Calcium, with 3,092 prescriptions and refills. In total Jae Y Yoo wrote 40,041 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 3,092 | 5,624 | 598 | $12K |
| Amlodipine Besylate Generic | 1,497 | 2,478 | 264 | $3,294 |
| Vascepa Icosapent Ethyl | 1,413 | 1,932 | 262 | $409K |
| Montelukast Sodium Generic | 1,247 | 1,862 | 223 | $5,839 |
| Metformin Hcl Generic | 1,184 | 2,171 | 228 | $8,893 |
| Losartan Potassium Generic | 1,115 | 2,130 | 222 | $5,142 |
| Donepezil Hcl Generic | 1,098 | 1,786 | 201 | $4,027 |
| Lidocaine Generic | 994 | 1,130 | 189 | $149K |
| Creon Lipase/Protease/Amylase | 950 | 1,061 | 201 | $1.0M |
| Olmesartan Medoxomil Generic | 940 | 1,580 | 177 | $6,479 |
| Metoprolol Succinate Generic | 902 | 1,520 | 166 | $5,718 |
| Gabapentin Generic | 830 | 1,144 | 160 | $3,981 |
| Omeprazole Generic | 817 | 1,261 | 201 | $3,026 |
| Amoxicillin Generic | 627 | 627 | 316 | $1,717 |
| Pantoprazole Sodium Generic | 614 | 908 | 124 | $2,463 |
Brand drugs: 7,562 claims; generic drugs: 32,211 claims; opioid claims: 337.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jae Y Yoo $238 ($238 in general payments such as food, travel and fees) from 5 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $82.12.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.